Specific Orbital Inflammatory Diseases

  • Alan A. McNab


Several specific inflammatory diseases may affect the orbit either in isolation or as part of a systemic disease process. Many of these will present with tumefactive lesions that may mimic neoplasia. The classic features of inflammation such as redness, swelling, pain, and loss of function may be absent, which may also lead to the impression of neoplasia. The conditions covered in this chapter include the granulomatous diseases sarcoidosis and the xanthogranulomatous processes, Sjögren’s syndrome, the vasculitic diseases granulomatosis with polyangiitis (GPA or Wegener’s granulomatosis) and eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome), and the recently recognized entity of IgG4-related disease. Sjögren’s syndrome and IgG4-related disease also carry an increased risk of the development of lymphoma, as occurs in many other chronic inflammatory diseases. The disease processes in this chapter have specific clinicopathological features, and their systemic manifestations may have significant impacts on the well-being of the patient, and establishing a diagnosis is of importance. A tissue biopsy is nearly always needed to establish a diagnosis, but additional serological tests may also be helpful.


Granulomatosis with polyangiitis IgG4-related disease Orbit Sarcoidosis Sjögren’s syndrome Xanthogranulomatous disease 


  1. 1.
    Prabhakaran VC, Saeed P, Esmaeli B, et al. Orbital and adnexal sarcoidosis. Arch Ophthalmol. 2007;125:1657–62.PubMedGoogle Scholar
  2. 2.
    Mavrikakis I, Rootman J. Diverse clinical presentations of orbital sarcoid. Am J Ophthalmol. 2007;144:760–75.Google Scholar
  3. 3.
    Demirci H, Christianson MD. Orbital and adnexal involvement in sarcoidosis: analysis of clinical features and systemic disease in 30 cases. Am J Ophthalmol. 2011;151:1074–80.PubMedGoogle Scholar
  4. 4.
    Sivak-Calcott JA, Rootman J, Rasmussen SL, et al. Adult xanthogranulomatous disease of the orbit and ocular adnexa: new immunohistochemical findings and clinical review. Br J Ophthalmol. 2006;90:602–8.Google Scholar
  5. 5.
    Satchi K, McNab AA, Godfrey T, et al. Adult orbital xanthogranuloma successfully treated with rituximab. Ophthalmology. 2014;121:1664–5.PubMedGoogle Scholar
  6. 6.
    Sagiv O, Thakar SD, Morell G, et al. Rituximab monotherapy is effective in treating orbital necrobiotic xanthogranuloma. Ophthal Plast Reconstr Surg. 2018;34:e24–7.PubMedGoogle Scholar
  7. 7.
    McKelvie P, McNab AA, Hardy TG, et al. Comparative study of clinical, pathological, radiological, and genetic features of patients with adult ocular adnexal xanthogranulomatous disease, Erdheim-Chester disease, and IgG4-related disease of the orbit/ocular adnexa. Ophthal Plast Reconstr Surg. 2017;33:112–9.PubMedGoogle Scholar
  8. 8.
    Rischmueller M, Tieu J, Lester S. Primary Sjögren’s syndrome. Best Pract Res Clin Rheumatol. 2016;30:189–220.PubMedGoogle Scholar
  9. 9.
    Parkin B, Chew JB, White VA, et al. Lymphocytic infiltration and enlargement of the lacrimal glands. A new subtype of primary Sjögren’s syndrome? Ophthalmology. 2005;112:2040–7.PubMedGoogle Scholar
  10. 10.
    Liang Y, Yang Z, Qin B, Zhong R. Primary Sjögren’s syndrome and malignancy risk: a systematic review and meta-analysis. Ann Rheum Dis. 2014;73:1151–6.PubMedGoogle Scholar
  11. 11.
    Tonami H, Matoba M, Yokata H, et al. Mucosa-associated lymphoid tissue lymphoma in Sjögren’s syndrome. Am J Roentgenol. 2002;179:485–9.Google Scholar
  12. 12.
    Cassidy DT, McKelvie P, Harris GJ, et al. Lacrimal gland orbital lobe cysts associated with MALT lymphoma and primary Sjögren’s syndrome. Orbit. 2005;24:257–63.PubMedGoogle Scholar
  13. 13.
    Muller K, Lin JH. Orbital granulomatosis with polyangiitis (Wegener granulomatosis). Arch Pathol Lab Med. 2014;138:1110–4.PubMedPubMedCentralGoogle Scholar
  14. 14.
    Harman LE, Margo CE. Wegener’s granulomatosis. Surv Ophthal. 1998;42:458–80.Google Scholar
  15. 15.
    Woo TL, Francis IC, Wilcsek GA. Australasian orbital and adnexal Wegener’s granulomatosis. Ophthalmology. 2001;108:1535–43.PubMedGoogle Scholar
  16. 16.
    Tan LT, Davagnanam I, Isa H, et al. Clinical and imaging features of orbital granulomatosis with polyangiitis and the risk of systemic involvement. Ophthalmology. 2014;121:1304–9.PubMedGoogle Scholar
  17. 17.
    Tan LT, Davagnanam I, Isa H, et al. Clinical and imaging features of lacrimal gland involvement in granulomatosis with polyangiitis. Ophthalmology. 2015;122:2125–9.PubMedGoogle Scholar
  18. 18.
    Lee BJ, Nelson CC, Lewis CD, et al. External dacryocystorhinostomy in patients with Wegener granulomatosis. Ophthal Plast Reconstr Surg. 2012;28:389–92.PubMedGoogle Scholar
  19. 19.
    Rosenbaum JT, Choi D, Wilson DJ, et al. Orbital pseudotumor can be a localized form of granulomatosis with polyangiitis as revealed by gene expression profiling. Exp Mol Pathol. 2015;99:271–8.PubMedPubMedCentralGoogle Scholar
  20. 20.
    Pakrou N, Selva D, Leibovitch I. Wegener’s granulomatosis: ophthalmic manifestations and management. Semin Arthritis Rheum. 2006;35:284–92.PubMedGoogle Scholar
  21. 21.
    Taylor SR, Salama AD, Joshi L, et al. Rituximab is effective in the treatment of refractory ophthalmic Wegener’s granulomatosis. Arthritis Rheum. 2009;60:1540–7.PubMedGoogle Scholar
  22. 22.
    McNab AA. Orbital inflammation in Churg-Strauss syndrome. Orbit. 1998;17:203–5.PubMedGoogle Scholar
  23. 23.
    Heine A, Beck R, Stropahi G, et al. Inflammatory pseudotumour of the anterior orbit. A symptom in allergic granulomatous angiitis (Churg-Strauss syndrome). Ophthalmologe. 1995;92:870–3.PubMedGoogle Scholar
  24. 24.
    Pradeep TG, Prabhakaran VC, McNab A, et al. Diffuse orbital inflammation in Churg-Strauss syndrome. Ophthal Plast Reconstr Surg. 2010;26:57–9.PubMedGoogle Scholar
  25. 25.
    Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732–8.PubMedGoogle Scholar
  26. 26.
    Deshpande V, Zen Y, Chan JKC, et al. Consensus statement on the pathology of IgG4-related disease. Hum Pathol. 2012;25:1181–92.Google Scholar
  27. 27.
    Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012;22:21–30.PubMedGoogle Scholar
  28. 28.
    Goto H, Takahira M, Azumi A, Japanese Study Group for IgG4-Related Ophthalmic Disease. Diagnostic criteria for IgG4-related ophthalmic disease. Jpn J Ophthalmol. 2015;59:1–7.PubMedGoogle Scholar
  29. 29.
    Chang SY, Keogh KA, Lewis JE, et al. IgG4-positive plasma cells in granulomatosis with polyangiitis (Wegener’s): a clinicopathological and immunohistochemical study on 43 granulomatosis with polyangiitis and 20 control cases. Hum Pathol. 2013;44:2432–7.PubMedGoogle Scholar
  30. 30.
    McNab AA, McKelvie P. IgG4-related ophthalmic disease. Part I: background and pathology. Ophthal Plast Reconstr Surg. 2015;31:83–8.PubMedGoogle Scholar
  31. 31.
    McNab AA, McKelvie P. IgG4-related ophthalmic disease. Part II: clinical aspects. Ophthal Plast Reconstr Surg. 2015;31:167–78.PubMedGoogle Scholar
  32. 32.
    Aziz HA, Villa-Forte A, Plesec TP, et al. Isolated conjunctival inflammation suggestive of IgG4-related disease. Ocul Oncol Pathol. 2015;2:51–3.PubMedPubMedCentralGoogle Scholar
  33. 33.
    Watanabe T, Fujinaga Y, Kawakami S, et al. Infraorbital nerve swelling associated with autoimmune pancreatitis. Jpn J Radiol. 2011;29:194–201.PubMedGoogle Scholar
  34. 34.
    Hardy TG, McNab AA, Rose GE. Enlargement of the infraorbital nerve: an important sign associated with orbital reactive lymphoid hyperplasia or IgG4-related inflammation. Ophthalmology. 2014;121:1297–303.PubMedGoogle Scholar
  35. 35.
    Cheuk W, Yuen HKL, Chan ACL, et al. Ocular adnexal lymphoma associated with IgG4+ chronic sclerosing dacryoadenitis: a previously undescribed complication of IgG4-related sclerosing disease. Am J Surg Pathol. 2008;32:1159–67.PubMedGoogle Scholar
  36. 36.
    Wallace ZS, Mattoo H, Carruthers M, et al. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis. 2015;74:190–5.PubMedGoogle Scholar
  37. 37.
    Ebbo M, Grados A, Guedj E, et al. Usefulness of 2-[18F]-flouro-2-deoxy-D-glucose-positron emission tomography/computed tomography for staging and evaluation of treatment response in IgG4-related disease: a retrospective multicenter study. Arthritis Care Res (Hoboken). 2014;66:86–96.Google Scholar
  38. 38.
    Khosroshahi A, Bloch DB, Deshpande V, et al. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum. 2010;62:1755–62.PubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Alan A. McNab
    • 1
  1. 1.Orbital Plastic and Lacrimal Clinic, Royal Victorian Eye and Ear HospitalMelbourneAustralia

Personalised recommendations